|
1
|
Saif MW: Advancements in the management of
pancreatic cancer: 2013. JOP. 14:112–118. 2013.PubMed/NCBI
|
|
2
|
Benavides M, Antón A, Gallego J, Gómez MA,
Jiménez-Gordo A, La Casta A, Laquente B, Macarulla T,
Rodríguez-Mowbray JR and Maurel J: Biliary tract cancers: SEOM
clinical guidelines. Clin Transl Oncol. 17:982–987. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shaffer EA: Gallbladder cancer: The
basics. Gastroenterol Hepatol (N Y). 4:737–741. 2008.
|
|
4
|
Im JH, Seong J, Lee IJ, Park JS, Yoon DS,
Kim KS, Lee WJ and Park KR: Surgery alone versus surgery followed
by chemotherapy and radiotherapy in resected extrahepatic bile duct
cancer: Treatment outcome analysis of 336 patients. Cancer Res
Treat. 48:583–595. 2016. View Article : Google Scholar :
|
|
5
|
Poruk KE, Firpo MA, Adler DG and Mulvihill
SJ: Screening for pancreatic cancer: Why, how, and who? Ann Surg.
257:17–26. 2013. View Article : Google Scholar
|
|
6
|
Zeng X and Tao H: Diagnostic and
prognostic serum marker of cholangiocarcinoma (Review). Oncol Lett.
9:3–8. 2015.
|
|
7
|
Ballehaninna UK and Chamberlain RS: The
clinical utility of serum CA 19-9 in the diagnosis, prognosis and
management of pancreatic adenocarcinoma: An evidence based
appraisal. J Gastrointest Oncol. 3:105–119. 2012.PubMed/NCBI
|
|
8
|
Lin MS, Huang JX and Yu H: Elevated serum
level of carbohydrate antigen 19-9 in benign biliary stricture
diseases can reduce its value as a tumor marker. Int J Clin Exp
Med. 7:744–750. 2014.PubMed/NCBI
|
|
9
|
Fong ZV and Winter JM: Biomarkers in
pancreatic cancer: Diagnostic, prognostic, and predictive. Cancer
J. 18:530–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ali S, Almhanna K, Chen W, Philip PA and
Sarkar FH: Differentially expressed miRNAs in the plasma may
provide a molecular signature for aggressive pancreatic cancer. Am
J Transl Res. 3:28–47. 2010.PubMed/NCBI
|
|
11
|
Ganepola GA, Rutledge JR, Suman P,
Yiengpruksawan A and Chang DH: Novel blood-based microRNA biomarker
panel for early diagnosis of pancreatic cancer. World J
Gastrointest Oncol. 6:22–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li A, Yu J, Kim H, Wolfgang CL, Canto MI,
Hruban RH and Goggins M: MicroRNA array analysis finds elevated
serum miR-1290 accurately distinguishes patients with low-stage
pancreatic cancer from healthy and disease controls. Clin Cancer
Res. 19:3600–3610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J,
Wang X, Gong Y, Wang W and Kong X: Combination of plasma microRNAs
with serum CA19-9 for early detection of pancreatic cancer. Int J
Cancer. 131:683–691. 2012. View Article : Google Scholar
|
|
14
|
Liu R, Chen X, Du Y, Yao W, Shen L, Wang
C, Hu Z, Zhuang R, Ning G, Zhang C, et al: Serum microRNA
expression profile as a biomarker in the diagnosis and prognosis of
pancreatic cancer. Clin Chem. 58:610–618. 2012. View Article : Google Scholar
|
|
15
|
Wang M, Wen TF, He LH, Li C, Zhu WJ and
Trishul NM: A six-microRNA set as prognostic indicators for bile
duct cancer. Int J Clin Exp Med. 8:17261–17270. 2015.
|
|
16
|
Stark A, Bushati N, Jan CH, Kheradpour P,
Hodges E, Brennecke J, Bartel DP, Cohen SM and Kellis M: A single
Hox locus in Drosophila produces functional microRNAs from opposite
DNA strands. Genes Dev. 22:8–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, et al:
Combined evaluation of a panel of protein and miRNA serum-exosome
biomarkers for pancreatic cancer diagnosis increases sensitivity
and specificity. Int J Cancer. 136:2616–2627. 2015. View Article : Google Scholar
|
|
19
|
Lin X, Lo HC, Wong DT and Xiao X:
Noncoding RNAs in human saliva as potential disease biomarkers.
Front Genet. 6:1752015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Palanisamy V, Sharma S, Deshpande A, Zhou
H, Gimzewski J and Wong DT: Nanostructural and transcriptomic
analyses of human saliva derived exosomes. PloS One. 5:e85772010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Humeau M, Vignolle-Vidoni A, Sicard F,
Martins F, Bournet B, Buscail L, Torrisani J and Cordelier P:
Salivary microRNA in pancreatic cancer patients. PLoS One.
10:e01309962015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang
X, Huang J, Zhang P, Zhou Z and Li Z: Salivary microRNAs show
potential as a noninvasive biomarker for detecting resectable
pancreatic cancer. Cancer Prev Res (Phila). 8:165–173. 2015.
View Article : Google Scholar
|
|
23
|
Michael A, Bajracharya SD, Yuen PS, Zhou
H, Star RA, Illei GG and Alevizos I: Exosomes from human saliva as
a source of microRNA biomarkers. Oral Dis. 16:34–38. 2010.
View Article : Google Scholar :
|
|
24
|
Gallo A and Alevizos I: Isolation of
circulating microRNA in saliva. Methods Mol Biol. 1024:183–190.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bahn JH, Zhang Q, Li F, Chan TM, Lin X,
Kim Y, Wong DT and Xiao X: The landscape of microRNA,
Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem.
61:221–230. 2015. View Article : Google Scholar :
|
|
26
|
Julious SA: Sample size of 12 per group
rule of thumb for a pilot study. Pharm Stat. 4:287–291. 2005.
View Article : Google Scholar
|
|
27
|
Chien HY, Lee TP, Chen CY, Chiu YH, Lin
YC, Lee LS and Li WC: Circulating microRNA as a diagnostic marker
in populations with type 2 diabetes mellitus and diabetic
complications. J Chin Med Assoc. 78:204–211. 2015. View Article : Google Scholar
|
|
28
|
Sessa R and Hata A: Role of microRNAs in
lung development and pulmonary diseases. Pulm Circ. 3:315–328.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schulte C and Zeller T: microRNA-based
diagnostics and therapy in cardiovascular disease-Summing up the
facts. Cardiovasc Diagn Ther. 5:17–36. 2015.PubMed/NCBI
|
|
30
|
Wei Q, Mi QS and Dong Z: The regulation
and function of microRNAs in kidney diseases. IUBMB Life.
65:602–614. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arrese M, Eguchi A and Feldstein AE:
Circulating microRNAs: Emerging biomarkers of liver disease. Semin
Liver Dis. 35:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qu Z, Li W and Fu B: MicroRNAs in
autoimmune diseases. BioMed Res Int. 2014:5278952014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Machida T, Tomofuji T, Ekuni D, Maruyama
T, Yoneda T, Kawabata Y, Mizuno H, Miyai H, Kunitomo M and Morita
M: MicroRNAs in salivary exosome as potential biomarkers of aging.
Int J Mol Sci. 16:21294–21309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schmittgen TD, Lee EJ, Jiang J, Sarkar A,
Yang L, Elton TS and Chen C: Real-time PCR quantification of
precursor and mature microRNA. Methods. 44:31–38. 2008. View Article : Google Scholar
|
|
35
|
Chen C, Tan R, Wong L, Fekete R and Halsey
J: Quantitation of microRNAs by real-time RT-qPCR. Methods Mol
Biol. 687:113–134. 2011. View Article : Google Scholar
|
|
36
|
Life Technologies: DataAssist v3.0
Software user instructions. 2011, http://cgs.hku.hk/portal/files/CGS/Genomics/Realtime-PCR/dataassist%20v3_0%20software%20user%20instructions.pdf.
|
|
37
|
Hajian-Tilaki K: Receiver Operating
Characteristic (ROC) Curve Analysis for medical diagnostic test
evaluation. Caspian J Intern Med. 4:627–635. 2013.PubMed/NCBI
|
|
38
|
Ruopp MD, Perkins NJ, Whitcomb BW and
Schisterman EF: Youden Index and optimal cut-point estimated from
observations affected by a lower limit of detection. Biom J.
50:419–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Swets JA: Measuring the accuracy of
diagnostic systems. Science. 240:1285–1293. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kojima M, Sudo H, Kawauchi J, Takizawa S,
Kondou S, Nobumasa H and Ochiai A: MicroRNA markers for the
diagnosis of pancreatic and biliary-tract cancers. PLoS One.
10:e01182202015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ali S, Saleh H, Sethi S, Sarkar FH and
Philip PA: MicroRNA profiling of diagnostic needle aspirates from
patients with pancreatic cancer. Br J Cancer. 107:1354–1360. 2012.
View Article : Google Scholar : PubMed/NCBI
|
